Frequency
The two drugmakers signed a development and commercialization agreement for an early stage prospective treatment for multiple myeloma.
5:08PM 08/19/08
Jim Cramer discusses Bristol-Myers Squibb and Imclone's battle for Erbitux and who will be THE cancer drug company.
02:14PM 08/11/08
Jim Cramer discusses Bristol-Myers Squibb and Imclone's battle for Erbitux and who will be THE cancer drug company.
12:53PM 08/11/08
Health stocks higher to close the week, Gilead reaches 52-week high.
5:08PM 08/08/08
The Mad About Options crew reviews Jim Cramer's recent bullish comments about Celgene and offers options strategies for traders and investors. Also, hear options ideas for Eastman Kodak and Alcoa.
09:29AM 08/08/08
Pharmaceutical makers outpaced biotech stocks on Monday.
4:50PM 08/04/08
ImClone says it's 'studying the situation' after receiving a $60-per-share bid from Bristol-Myers.
5:57PM 07/31/08
The stock soars well above the $60 that Bristol-Myers is offering.
3:09PM 07/31/08
The sector is trading higher on today's buyout bid. One analyst offers a list of who else could tie the knot in the drug and biotech space.
12:44PM 07/31/08
ImClone shares are soaring on news of the $4.5 billion cash bid.
8:59PM 07/30/08
Our Experts' Take at RealMoney
The lack of fear in the markets, despite a wealth of bad news, may be bad news itself.
7:03AM 08/20/08
The stock appears to be forming a base, but be cautious about stop placement.
2:00PM 08/18/08
More Experts' Takes
More popular tickers are indicated by scale.
